Chronic heart valve regurgitation induces left ventricular (LV) volume overload, leading to the development of hypertrophy and progressive dilatation of the ventricle to maintain physiological cardiac output. In order to prevent potential irreversible LV structural changes, the identification of the best timing for treatment is pivotal.
Myocardial fibrosis in asymptomatic patients undergoing surgery for mitral and aortic valve regurgitation
De Bonis, Michele;Pappalardo, Federico;Castiglioni, Alessandro;Maisano, Francesco;Zangrillo, Alberto;Ambrosi, Alessandro;Doglioni, Claudio;Alfieri, Ottavio;Margonato, Alberto
2022-01-01
Abstract
Chronic heart valve regurgitation induces left ventricular (LV) volume overload, leading to the development of hypertrophy and progressive dilatation of the ventricle to maintain physiological cardiac output. In order to prevent potential irreversible LV structural changes, the identification of the best timing for treatment is pivotal.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
BEM-JCM 2022.pdf
solo gestori archivio
Tipologia:
Submitted manuscript (manoscritto inviato all’editore)
Licenza:
Altra licenza OA
Dimensione
1.7 MB
Formato
Adobe PDF
|
1.7 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
